Technologies and innovations that are closer to market and able to generate commercial interest are supported through the Medical Technologies IKC’s co-development projects. These are larger projects, match funded with industry with a value of between £200k-£400k and may follow on from proof of concept projects, with the IP usually held by the Medical Technologies IKC and licensed to the industry partner. The aim of the projects is to take the innovation through to technology readiness level five (TRL 5).
The Medical Technologies IKC has funded six co-development projects to date, working with DePuy Synthes, Simulation Solutions, Tissue Regenix, NHS Blood and Transplant, Invibio and Credentis. The projects have helped to develop next generation hybrid hip replacements, natural knee simulation systems, tissue engineered replacement menisci and anterior cruciate ligaments and new materials for knee replacements and to treat and repair tooth decay.
Combining the Medical Technologies IKC’s experience of the orthopaedics sector and our experience in industry was a good marriage for moving our methodology forward.
Anthony Odell, Tissue Regenix